Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad)
NASDAQ:IRON

Disc Medicine Q1 2023 Earnings Report

Disc Medicine logo
$49.51 -0.17 (-0.34%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$49.52 +0.01 (+0.02%)
As of 05/2/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings HistoryForecast

Disc Medicine EPS Results

Actual EPS
-$1.20
Consensus EPS
-$0.67
Beat/Miss
Missed by -$0.53
One Year Ago EPS
N/A

Disc Medicine Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Disc Medicine Announcement Details

Quarter
Q1 2023
Date
5/15/2023
Time
Before Market Opens
Conference Call Date
Monday, May 15, 2023
Conference Call Time
7:00AM ET

Upcoming Earnings

Disc Medicine's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Tuesday, May 13, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Conference Call Resources

Powered by Quartr

Earnings Documents

Disc Medicine's Q1 2023 Press ReleasePress Release
(8-K)
Disc Medicine's Q1 2023 Quarterly reportQuarterly report
(10-Q)

Disc Medicine Earnings Headlines

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Disc Medicine (IRON) and Roche Holding (OtherRHHBY)
April 9, 2025 | markets.businessinsider.com
Disc Medicine: Forging Ahead In Hematology
April 9, 2025 | seekingalpha.com
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
May 4, 2025 | Premier Gold Co (Ad)
Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode?
March 27, 2025 | msn.com
With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing
March 23, 2025 | uk.finance.yahoo.com
Victoria’s Secret, Bitdeer, and More Stocks See Activist Action
March 21, 2025 | msn.com
See More Disc Medicine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Disc Medicine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Disc Medicine and other key companies, straight to your email.

About Disc Medicine

Disc Medicine (NASDAQ:IRON), together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

View Disc Medicine Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles